Rocket Pharmaceuticals (RCKT) News Today

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) shares have declined amid a wave of class action filings and investor alerts tied to the FDA’s clinical hold on its RP-A501 trial and related securities-fraud allegations. Multiple law firms are urging shareholders to file lead-plaintiff motions by August 11, 2025. Key developments include:

• Negative Sentiment: Portnoy Law Firm is offering Rocket investors a no-cost option to recover losses and reminds shareholders of the August 11, 2025 deadline to file a lead plaintiff motion. Rocket Pharmaceuticals, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. August 11, 2025 Deadline to file Lead Plaintiff Motion
• Negative Sentiment: Glancy Prongay & Murray LLP warns investors who purchased RCKT between September 17, 2024 and May 26, 2025 of an August 11 lead-plaintiff filing deadline in a securities-fraud suit. Deadline Alert: Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
• Negative Sentiment: Pomerantz LLP issues an investor alert, reminding RCKT shareholders of a class action over trading losses and advising contact by August 11. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT
• Negative Sentiment: Hagens Berman highlights that the May 27 FDA hold on RP-A501 led to a >60% one-day share plunge and has spawned a class action seeking damages. RCKT 10-DAY DEADLINE ALERT: FDA Clinical Hold on RP-A501 Trial Triggers Rocket Pharmaceuticals (RCKT) Stock Plunge and Class Action – Hagens Berman
• Negative Sentiment: Levi & Korsinsky notifies Rocket investors of a securities-fraud class action covering September 17, 2024 to May 26, 2025 and reminds them of the August 11 deadline. Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - RCKT
• Negative Sentiment: Berger Montague PC advises RCKT shareholders to inquire about a class action over alleged concealment of RP-A501 safety issues, with an August 11 lead-plaintiff cutoff. ROCKET PHARMACEUTICALS (NASDAQ: RCKT) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by August 11, 2025
• Negative Sentiment: Rosen Law Firm alerts investors with losses over $100K to secure lead-plaintiff status by August 11 in the pending securities-fraud suit. RCKT Deadline: RCKT Investors with Losses in Excess of $100K Have Opportunity to Lead Rocket Pharmaceuticals, Inc. Securities Fraud Lawsuit
• Negative Sentiment: Levi & Korsinsky again reminds investors of the class action and the August 11 lead-plaintiff deadline. Levi & Korsinsky Reminds Rocket Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025 – RCKT
• Negative Sentiment: Bronstein, Gewirtz & Grossman LLC notifies shareholders of an opportunity to lead the class action over alleged misstatements and lost shareholder value. RCKT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
• Negative Sentiment: Rosen Law Firm issues another reminder for investors with losses above $100K to act before the August 11 class-action deadline. RCKT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. Investors with Losses in Excess of 100K to Secure Counsel Before Important August 11 Deadline in Securities Class Action – RCKT
• Negative Sentiment: The Law Offices of Frank R. Cruz announces an opportunity for investors who lost money in RCKT to seek lead-plaintiff status in the securities fraud action. Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
• Negative Sentiment: Pomerantz LLP’s July 31 alert similarly reminds investors of the class action and the impending August 11 deadline. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT
• Negative Sentiment: The Gross Law Firm encourages RCKT shareholders to contact them before August 11 to discuss lead-plaintiff options in the securities-fraud suit. Investors in Rocket Pharmaceuticals, Inc. Should Contact The Gross Law Firm Before August 11, 2025 to Discuss Your Rights - RCKT